Evolus, Inc.

Healthcare

NASDAQ:EOLS · NASDAQ Global Market

Market Cap $428.71M Beta 1.33 P/E (TTM) -10.1

$6.73 +3.38%

+$0.22 today

52W Low $3.86High $10.27

Vol 0.63M · Avg 0.87M

EPS (TTM)-$0.67

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-32.23%

Period High

$9.96

Period Low

$3.94

Latest

$6.73

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Enhabit, Inc.

EHAB

$706.91M

CeriBell, Inc.

NASDAQ:CBLL

$700.80M

Solid Biosciences Inc.

NASDAQ:SLDB

$556.28M

The Oncology Institute, Inc.

NASDAQ:TOI

$530.91M

Neurogene Inc.

NASDAQ:NGNE

$459.84M

OrthoPediatrics Corp.

NASDAQ:KIDS

$457.71M

Kamada Ltd.

NASDAQ:KMDA

$429.18M

Autolus Therapeutics plc

NASDAQ:AUTL

$415.18M

Treace Medical Concepts, Inc.

NASDAQ:TMCI

$263.38M

Quantum-Si incorporated

NASDAQ:QSI

$187.28M

What is the latest EOLS filing?

The latest filing shown is 8-K dated Jun 12, 2026.

How many recent filings does EOLS have?

Intrinsic Alpha currently shows 20 recent filings for EOLS.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.